Integrated endometrial cancer stage using the 2023 FIGO molecular framework.
Calculated Interpretation
IA1
Use the integrated 2023 FIGO stage after combining anatomy with POLE/MMR/p53 information where available.
Guidelines & Evidence
Clinical Details
Section 1
When to Use
Primary Use
Integrated endometrial cancer stage using the 2023 FIGO molecular framework.
Section 2
Formula & Logic
Clinical Inputs
Integrated FIGO stage
Categorical selection
Section 3
Pearls/Pitfalls
Result Bands
Section 4
Next Steps
Suggested Next Steps
01
Interpret the result in the full disease-specific clinical context.
02
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.
Section 5
Evidence Appraisal
Evidence Base
Integrated endometrial cancer stage using the 2023 FIGO molecular framework.
OpiCalc Medical Oncology Module • Gynaecological Cancers. 2026;Logic implemented from widely used contemporary oncology classification, prognostic, and response-assessment frameworks.
Section 6
Literature
Context
FIGO 2023 (Endometrial) is included in the oncology module as a structured decision-support tool for gynaecological cancers workflows.
